Tzetis Maria, Mitrakos Anastasios, Papathanasiou Ioanna, Koute Vasiliki, Kosma Konstantina, Pons Roser, Michoula Aspasia, Grivea Ioanna, Tsezou Aspasia
Laboratory of Medical Genetics, Medical School, National and Kapodistrian University of Athens, Thivon & Levadias, 11527 Athens, Greece.
Medical Genetics Laboratory, GeneTech Analytics Ltd., 41 Asklepiou, 41222 Larissa, Greece.
Genes (Basel). 2025 Apr 29;16(5):521. doi: 10.3390/genes16050521.
Kleefstra syndrome 1(KLEFS1, OMIM#610253) is a rare neurodevelopmental disorder (NDD) instigated by heterozygous variants or microdeletions occurring in the 9q34.4 genomic region of the euchromatic histone methyltransferase-1 () gene and is inherited in an autosomal dominant (AD) manner. The clinical phenotype of KLEFS1 includes moderate to severe intellectual disability (ID), hypotonia, and distinctive facial features and additionally involves other organ systems (heart, renal, genitourinary, sensory) albeit with phenotypic heterogeneity between patients. The purpose of this study is to expand the genotypic spectrum of KLEFS1 and compare phenotypic features of the syndrome of already published cases.
Exome sequencing (ES), chromosomal microarray analysis (CMA), as well as sanger sequencing, for confirmation of the de novo status of the frameshift variant, were used.
Here we describe two more cases, both males with a similar age and carriers of novel variants; one with a frameshift variant involving exon 13: p.Val692Glyfs*64 and the other with the smallest so far described, 11 Kb (exons 19-25), 9q34.4 microdeletion: 9q34.3 (140703393-140714454). Both presented with an NDD disorder with one showing more severe ID with significant social disabilities, while the other with the microdeletion had mild ID and following a normal education curriculum. Neither of them were obese nor had any other significant organ system disorder.
The observed phenotypic variability due to genotypic differences in the two children contributes to the expanding spectrum of KLEFS1 disease phenotypes.
克莱夫斯特拉综合征1型(KLEFS1,OMIM#610253)是一种罕见的神经发育障碍(NDD),由常染色质组蛋白甲基转移酶-1()基因9q34.4基因组区域发生的杂合变异或微缺失引发,以常染色体显性(AD)方式遗传。KLEFS1的临床表型包括中度至重度智力残疾(ID)、肌张力减退和独特的面部特征,此外还累及其他器官系统(心脏、肾脏、泌尿生殖系统、感觉系统),尽管患者之间存在表型异质性。本研究的目的是扩大KLEFS1的基因型谱,并比较已发表病例中该综合征的表型特征。
使用外显子组测序(ES)、染色体微阵列分析(CMA)以及桑格测序来确认移码变异的从头状态。
在此我们描述另外两例病例,均为年龄相仿的男性,且携带新变异;一例为涉及外显子13的移码变异:p.Val692Glyfs*64,另一例为迄今为止描述的最小的9q34.4微缺失,11 Kb(外显子19 - 25):9q34.3(140703393 - 140714454)。两者均表现为神经发育障碍,其中一例显示更严重的智力残疾及显著的社交障碍,而另一例微缺失患者智力残疾较轻,接受正常教育课程。他们均未肥胖,也无任何其他重大器官系统疾病。
两个孩子因基因型差异所观察到的表型变异性,有助于扩大KLEFS1疾病表型谱。